Suchergebnisse - "Billioti de Gage, Sophie"

PubPharm (7)

1

Roll-out and effectiveness of HIV pre-exposure prophylaxis in France : An overview

enthalten in: Therapie | 2023

von Billioti de Gage, S. | Jourdain, H. | Desplas, D. | +1

2

Roll-out of HIV pre-exposure prophylaxis use in France : A nationwide observational study from 2016 to 2021

enthalten in: The Lancet regional health. Europe | 2022

von Billioti de Gage, S. | Desplas, D. | Dray-Spira, R.

3

Risk of Myocardial Infarction, Stroke, or Death in New Users of Intravitreal Aflibercept Versus Ranibizumab : A Nationwide Cohort Study

enthalten in: Ophthalmology and therapy | 2022

von Billioti de Gage, S. | Bertrand, M. | Grimaldi, S. | +1

4

Intravitreal anti-VEGF use in France : a cross-sectional and longitudinal Nationwide observational study

enthalten in: Acta ophthalmologica | 2022

von Billioti de Gage, S. | Bertrand, M. | Grimaldi, S. | +1

5

Risk of Myocardial Infarction, Stroke, or Death in New Users of Intravitreal Aflibercept Versus Ranibizumab: A Nationwide Cohort Study

enthalten in: Ophthalmology and therapy | 2022

von Billioti de Gage, S. | Bertrand, M. | Grimaldi, S. | +1

6

Risk of Myocardial Infarction, Stroke, or Death in New Users of Intravitreal Aflibercept Versus Ranibizumab: A Nationwide Cohort Study

enthalten in: Ophthalmology and therapy | 2022

von Billioti de Gage, S. | Bertrand, M. | Grimaldi, S. | +1

7

Intravitreal Anti-Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic

enthalten in: JAMA ophthalmology | 2021

von Billioti de Gage, S. | Drouin, J. | Desplas, D. | +4

ErratumIn: JAMA Ophthalmol. 2021 Feb 1;139(2):256. - PMID 33595604

1
[1]